Natco Pharma launches higher strength anti-cancer generic drug in U.S.
The Hindu
Natco Pharma on Friday said marketing partner Breckenridge Pharmaceutical Inc. has launched 10 mg strength of Everolimus Tablets (generic for Afinitor) in the US market. The drug is used in the treatm
Natco Pharma on Friday said marketing partner Breckenridge Pharmaceutical Inc. has launched 10 mg strength of Everolimus Tablets (generic for Afinitor) in the US market.
The drug is used in the treatment of certain cancer. USFDA had previously granted final approval for this ANDA.
The 10mg strength of Afinitor had generated annual sales of $392 million during the twelve months ending July 2021, it said citing industry sales data.
More Related News